Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Share-based Compensation (2019 - 2025)

Historic Share-based Compensation for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to $1.4 million.

  • AVITA Medical's Share-based Compensation fell 5092.92% to $1.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.5 million, marking a year-over-year decrease of 2946.8%. This contributed to the annual value of $9.5 million for FY2025, which is 2946.8% down from last year.
  • Per AVITA Medical's latest filing, its Share-based Compensation stood at $1.4 million for Q4 2025, which was down 5092.92% from $2.8 million recorded in Q3 2025.
  • AVITA Medical's 5-year Share-based Compensation high stood at $4.1 million for Q3 2024, and its period low was $1.1 million during Q2 2023.
  • In the last 5 years, AVITA Medical's Share-based Compensation had a median value of $2.4 million in 2023 and averaged $2.3 million.
  • As far as peak fluctuations go, AVITA Medical's Share-based Compensation tumbled by 8526.75% in 2021, and later soared by 25231.85% in 2024.
  • AVITA Medical's Share-based Compensation (Quarter) stood at $1.8 million in 2021, then tumbled by 33.98% to $1.2 million in 2022, then soared by 78.54% to $2.2 million in 2023, then increased by 28.88% to $2.8 million in 2024, then crashed by 50.93% to $1.4 million in 2025.
  • Its Share-based Compensation was $1.4 million in Q4 2025, compared to $2.8 million in Q3 2025 and $2.7 million in Q2 2025.